Research Topics
Genomes and Genes
Species | Yasushi YatabeSummaryAffiliation: Aichi Cancer Center Country: Japan Publications
| Collaborators
|
Detail Information
Publications
Epidermal growth factor receptor mutations in lung cancersYasushi Yatabe
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan
Pathol Int 57:233-44. 2007..In the present study the current knowledge of EGFR mutations is reviewed, insights from which raise many further questions, and thus suggest new directions for future research...
[Molecular diagnosis of lung cancer in association with treatment of choice]Yasushi Yatabe
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya 464 8681, Japan
Rinsho Byori 60:786-95. 2012..More recently, similar marked responses to an ALK inhibitor in patients with ALK fusion lung cancers were demonstrated. In this article, we review such recent advances in lung cancer, focusing on EGFR mutation and ALK fusion....
EGFR mutations and the terminal respiratory unitYasushi Yatabe
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Kanokoden, Chikusa ku, Nagoya, 464 8681, Japan
Cancer Metastasis Rev 29:23-36. 2010..quot;..
Maspin expression in normal lung and non-small-cell lung cancers: cellular property-associated expression under the control of promoter DNA methylationYasushi Yatabe
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan
Oncogene 23:4041-9. 2004..Separate analysis of methylation status in positive and negative portions of individual tumors provided an instance of intratumor diversity associated with promoter DNA methylation...
CK20 expression, CDX2 expression, K-ras mutation, and goblet cell morphology in a subset of lung adenocarcinomasYasushi Yatabe
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan
J Pathol 203:645-52. 2004..However, some lung adenocarcinomas may express CDX2 strongly: in this case, CK20 also tends to be positive...
EGFR mutation is specific for terminal respiratory unit type adenocarcinomaYasushi Yatabe
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan
Am J Surg Pathol 29:633-9. 2005..These findings further confirm that TRU-type-adenocarcinoma is a distinct adenocarcinoma subset in which a particular molecular pathway is involved...
Do all lung adenocarcinomas follow a stepwise progression?Yasushi Yatabe
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
Lung Cancer 74:7-11. 2011..In this review, we hypothesize a novel scenario for the progression of lung adenocarcinoma, which does not support a linear progression schema...
Heterogeneous distribution of EGFR mutations is extremely rare in lung adenocarcinomaYasushi Yatabe
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
J Clin Oncol 29:2972-7. 2011..Some studies have shown that epidermal growth factor receptor (EGFR) mutations can be heterogeneously distributed in individual tumors. In this study, we re-evaluated the distribution of EGFR mutations within tumors...
A rapid, sensitive assay to detect EGFR mutation in small biopsy specimens from lung cancerYasushi Yatabe
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Kanokoden, Nagoya 464 8681, Japan
J Mol Diagn 8:335-41. 2006..In conclusion, the assay is a rapid, sensitive method using paraffin sections of biopsy specimens without a tumor cell-enrichment procedure and is quite useful to select a treatment of choice in clinical practice...
Decreased expression of 14-3-3sigma in neuroendocrine tumors is independent of origin and malignant potentialYasushi Yatabe
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan
Oncogene 21:8310-9. 2002....
TTF-1 expression in pulmonary adenocarcinomasYasushi Yatabe
Department of Anatomic and Molecular Diagnostic Pathology, Aichi Cancer Center Hospital, Aichi Cancer Center Research Institute, Nagoya, Japan
Am J Surg Pathol 26:767-73. 2002..01), less frequent RB loss (p <0.05), and preserved expression of p27 (p <0.01). The results supported the TTF-1 lineage marker and suggested that molecular pathogenesis may in part be characterized by cellular lineage...
Epidermal growth factor receptor gene amplification is acquired in association with tumor progression of EGFR-mutated lung cancerYasushi Yatabe
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya 464 8681, Japan
Cancer Res 68:2106-11. 2008..Taken together, our results show that mutation occurs early in the development of lung adenocarcinoma, and that amplification may be acquired in association with tumor progression...
Epithelial to mesenchymal transition in an epidermal growth factor receptor-mutant lung cancer cell line with acquired resistance to erlotinibKenichi Suda
Department of Thoracic Surgery, Aichi Cancer Center Hospital, Chikusa ku, Nagoya, Japan
J Thorac Oncol 6:1152-61. 2011..However, recent clinical studies revealed that gefitinib or erlotinib are highly effective in the treatment of non-small cell lung cancer with EGFR mutations...
Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancersRyoichi Onozato
Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
J Thorac Oncol 4:5-11. 2009..The purpose of this study was to clarify in the role of MET activation in lung carcinogenesis...
Mutations of the epidermal growth factor receptor gene predict prolonged survival after gefitinib treatment in patients with non-small-cell lung cancer with postoperative recurrenceTetsuya Mitsudomi
Department of Thoracic Surgery, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
J Clin Oncol 23:2513-20. 2005..To evaluate the relationship between mutations of the epidermal growth factor receptor (EGFR) gene and the effectiveness of gefitinib treatment in patients with recurrent lung cancer after pulmonary resection...
hOGG1 Ser326Cys polymorphism and risk of lung cancer by histological typeToshiki Okasaka
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
J Hum Genet 54:739-45. 2009..These results indicate that rs1052133 contributes to the risk of adenocarcinoma of lung...
Stepwise examination for differential diagnosis of primary lung cancer and breast cancer relapse presenting as a solitary pulmonary nodule in patients after mastectomyToshiki Okasaka
Division of Thoracic Surgery, Nagoya University Graduate School of Medicine, Showa Ku, Nagoya, Japan
J Surg Oncol 98:510-4. 2008..Definitive diagnosis of these nodules, however, is often difficult. We assessed the feasibility of our diagnostic approach for these nodules and estimated the frequency of primary lung cancer occurrence in patients after mastectomy...
mRNA expression of RRM1, ERCC1 and ERCC2 is not associated with chemosensitivity to cisplatin, carboplatin and gemcitabine in human lung cancer cell linesJunichi Shimizu
Department of Thoracic Oncology, Aichi Cancer Center Hospital, Aichi, Japan
Respirology 13:510-7. 2008..The aim of this study was to test whether similar associations would be seen between mRNA expression for the RRM1, ERCC1 and ERCC2 genes and in vitro chemosensitivity in lung cancer...
Roles of achaete-scute homologue 1 in DKK1 and E-cadherin repression and neuroendocrine differentiation in lung cancerHirotaka Osada
Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya 464 8681, Japan
Cancer Res 68:1647-55. 2008....
Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinomaTakayuki Kosaka
Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
J Thorac Oncol 4:22-9. 2009..We examined for EGFR, KRAS or TP53 mutations in a consecutive large cohort of patients with lung adenocarcinoma, and evaluated their prognostic impact...
Subcategorization of lung cancer based on tumor size and degree of visceral pleural invasionNoriaki Sakakura
Department of Thoracic Surgery, Division of Epidemiology and Prevention, Aichi Cancer Center Hospital, Nagoya, Japan
Ann Thorac Surg 86:1084-90. 2008..Lung cancer staging system proposed in 2007 adopts detailed tumor size cut-off values. Alternatively, visceral pleural invasion is deemed an important prognosticator, but has not been easily incorporated into the staging system...
Soy consumption reduces the risk of non-small-cell lung cancers with epidermal growth factor receptor mutations among JapaneseKeitaro Matsuo
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
Cancer Sci 99:1202-8. 2008..023). In conclusion, soy consumption may exert a protective association against the development of NSCLCs with EGFR mutations, providing possible insights into mechanisms of their genesis...
YAP1 is involved in mesothelioma development and negatively regulated by Merlin through phosphorylationToshihiko Yokoyama
Division of Molecular Oncology, Aichi Cancer Center Research Institute, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
Carcinogenesis 29:2139-46. 2008..Future studies of transcriptional targets of YAP1 in MPMs may shed light on the molecular mechanisms of MPM development and lead to new therapeutic strategies...
Lineage-specific dependency of lung adenocarcinomas on the lung development regulator TTF-1Hisaaki Tanaka
Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan
Cancer Res 67:6007-11. 2007....
Effects of genetic polymorphisms in the ABCB1 gene on clinical outcomes in patients with gastric cancer treated by second-line chemotherapyKohei Shitara
Department of Clinical Oncology, Aichi Cancer Center Hospital, Japan
Asian Pac J Cancer Prev 11:447-52. 2010..The purpose of this analysis was to evaluate the impact of genetic polymorphisms of the ABCB1 gene on clinical outcomes in patients with advanced gastric cancer (AGC) treated with second-line chemotherapy...
Docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancerTomoya Yokota
Department of Clinical Oncology, Aichi Cancer Center Hospital, Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
Anticancer Res 31:3535-41. 2011..This study aimed to evaluate the efficacy of docetaxel plus 5-fluorouracil and cisplatin (DCF) induction chemotherapy for locally advanced borderline-resectable T4 esophageal cancer...
Clinical outcomes of advanced non-small cell lung cancer patients screened for epidermal growth factor receptor gene mutationsKimihide Yoshida
Department of Thoracic Oncology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya, 464 8681, Japan
J Cancer Res Clin Oncol 136:527-35. 2010..To evaluate the relationship between the epidermal growth factor receptor (EGFR) mutation status and the effectiveness of gefitinib monotherapy or chemotherapy in patients with advanced non-small cell lung cancer (NSCLC)...
Selected polymorphisms of base excision repair genes and pancreatic cancer risk in JapaneseMakoto Nakao
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
J Epidemiol 22:477-83. 2012..We assessed the impact of genetic polymorphisms in the base excision repair (BER) pathway on PC risk among Japanese...
Folate, alcohol, and aldehyde dehydrogenase 2 polymorphism and the risk of oral and pharyngeal cancer in JapaneseKeitaro Matsuo
Division of Epidemiology and Prevention, Aichi Cancer Center Hospital, Nagoya University Graduate School of Medicene, Nagoya, Japan
Eur J Cancer Prev 21:193-8. 2012..Interaction between folate consumption, drinking, and ALDH2 genotype was remarkable (three-way interaction, P<0.001). We observed significant interaction among folate, drinking, and ALDH2 genotype in the Japanese population...
Prospective validation for prediction of gefitinib sensitivity by epidermal growth factor receptor gene mutation in patients with non-small cell lung cancerKimihide Yoshida
Department of Thoracic Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
J Thorac Oncol 2:22-8. 2007..We evaluated the efficacy of gefitinib monotherapy prospectively in patients with advanced or pretreated non-small cell lung cancer (NSCLC) harboring epidermal growth factor receptor (EGFR) mutations...
Impact of smoking on lung cancer risk is stronger in those with the homozygous aldehyde dehydrogenase 2 null allele in a Japanese populationJi Young Park
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8618, Japan
Carcinogenesis 31:660-5. 2010..036) and was consistently observed in the analysis among never-drinkers (interaction P = 0.041). These results suggest that ALDH2 Lys/Lys, a null enzyme activity genotype, modifies the impact of smoking on the risk of lung cancer...
Frequent and histological type-specific inactivation of 14-3-3sigma in human lung cancersHirotaka Osada
Division of Molecular Oncology, Aichi Cancer Center Research Institute, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
Oncogene 21:2418-24. 2002....
Diagnostic approach to pancreatic tumors with the specimens of endoscopic ultrasound-guided fine needle aspirationWaki Hosoda
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan
Pathol Int 60:358-64. 2010..The usefulness of these markers was confirmed using 13 additional pancreatic tumors, prospectively. Although minimal in selection, these markers are helpful in making diagnosis from EUS-FNA specimens of the major pancreatic tumors...
Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinibTakayuki Kosaka
Department of Thoracic Surgery, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan
Clin Cancer Res 12:5764-9. 2006..CONCLUSIONS: A secondary T790M mutation of EGFR accounted for half the tumors with acquired resistance to gefitinib in Japanese patients. Other drug-resistant secondary mutations are uncommon in the EGFR gene...
Novel metastasis-related gene CIM functions in the regulation of multiple cellular stress-response pathwaysKiyoshi Yanagisawa
Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan
Cancer Res 70:9949-58. 2010....
Cycleave polymerase chain reaction method is practically applicable for V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog (KRAS)/V-raf murine sarcoma viral oncogene homolog B1 (BRAF) genotyping in colorectal cancerTomoya Yokota
Department of Clinical Oncology, Aichi Cancer Center Hospital, Kanokoden, Chikusa ku, Nagoya, Japan
Transl Res 156:98-105. 2010..In conclusion, cycleave PCR is practically applicable to KRAS/BRAF genotyping using small amounts of biopsied tumor cells. Care must be taken in the selection of pathological specimens for KRAS/BRAF testing...
miR-375 is activated by ASH1 and inhibits YAP1 in a lineage-dependent manner in lung cancerEri Nishikawa
Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan
Cancer Res 71:6165-73. 2011..Our results elucidate an ASH1 effector axis in NE-lung cancers that is functionally pivotal in controlling NE features and the alleviation from YAP1-mediated growth inhibition...
Impact of one-carbon metabolism-related gene polymorphisms on risk of lung cancer in Japan: a case control studyTakeshi Suzuki
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
Carcinogenesis 28:1718-25. 2007..Further evaluation is warranted...
Comparison between self-reported facial flushing after alcohol consumption and ALDH2 Glu504Lys polymorphism for risk of upper aerodigestive tract cancer in a Japanese populationIsao Oze
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
Cancer Sci 101:1875-80. 2010..Facial flushing was less useful to predict UAT cancer risk than genotyping ALDH2 polymorphism...
Efficacy of erlotinib for brain and leptomeningeal metastases in patients with lung adenocarcinoma who showed initial good response to gefitinibTatsuya Katayama
Department of Thoracic Surgery, Aichi Cancer Center Hospital, Chikusa ku, Nagoya, Japan
J Thorac Oncol 4:1415-9. 2009..We speculate that erlotinib, instead of high dose of gefitinib, may be also effective for the treatment of central nervous system (CNS) lesions, as trough serum concentration of erlotinib is nine times higher than that of gefitinib...
HLA-A alleles and the risk of cervical squamous cell carcinoma in Japanese womenSatoyo Hosono
Deparment of Gynecology and Obstetrics, Nagoya University Graduate School of Medicine, Nagoya, Japan
J Epidemiol 20:295-301. 2010..We conducted a case-control study to examine the relationship between human leukocyte antigen-A (HLA-A) allele polymorphism and the pathogenesis of cervical neoplasia among Japanese women...
Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reactionHideki Endoh
Department of Thoracic Surgery, Aichi Cancer Center, Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
J Clin Oncol 22:811-9. 2004....
HNF4α as a Marker for Invasive Mucinous Adenocarcinoma of the LungMasato Sugano
Departments of Pathology and Molecular Diagnostics Thoracic Oncology Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
Am J Surg Pathol 37:211-8. 2013....
Association between a genome-wide association study-identified locus and the risk of lung cancer in Japanese populationHidemi Ito
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
J Thorac Oncol 7:790-8. 2012..To examine the impact of 15p25 and 5p15 on lung cancer risk and smoking intensity, we conducted a case-control study in Japanese population. We also examined whether these loci modify the effect of smoking behavior on lung cancer risk...
A genetic risk predictor for breast cancer using a combination of low-penetrance polymorphisms in a Japanese populationAiko Sueta
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, 1 1, Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
Breast Cancer Res Treat 132:711-21. 2012..Risk models which include a genetic risk score are possibly useful in distinguishing women at high risk of breast cancer from those at low risk, particularly in the context of targeted prevention...
LKB1 gene mutations in Japanese lung cancer patientsRyoichi Onozato
Department of Thoracic Surgery, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya, Japan
Cancer Sci 98:1747-51. 2007..LKB1 gene mutations appear to be frequent in male, smoking patients of Caucasian origin, in contrast to EGFR or HER2 mutations that are frequent in non-smoking, female patients of Asian origin...
Combined inhibition of MET and EGFR suppresses proliferation of malignant mesothelioma cellsKoji Kawaguchi
Division of Molecular Oncology, Aichi Cancer Center Research Institute, 1 1 Kanokoden, Chikusa ku, Nagoya, Japan
Carcinogenesis 30:1097-105. 2009....
Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancersKenji Tomizawa
Department of Thoracic Surgery, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
Lung Cancer 74:139-44. 2011..However its prognostic and predictive implications are not yet established...
Proteasomal non-catalytic subunit PSMD2 as a potential therapeutic target in association with various clinicopathologic features in lung adenocarcinomasYasushi Matsuyama
Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan
Mol Carcinog 50:301-9. 2011....
Effect of gefitinib on the survival of patients with recurrence of lung adenocarcinoma after surgery: a retrospective case-matching cohort studyTatsuya Katayama
Department of Thoracic Surgery, Aichi Cancer Center Hospital, 1 1 Kanokoden, Nagoya, Japan
Surg Oncol 19:e144-9. 2010....
Clinical impact of K-ras mutation analysis in EUS-guided FNA specimens from pancreatic massesTakeshi Ogura
Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan
Gastrointest Endosc 75:769-74. 2012..EUS-guided FNA (EUS-FNA) is considered optimal for differentially diagnosing pancreatic masses. However, the sensitivity of EUS-FNA ranges from 65% to 95%, respectively, which requires improvement...
Association between an 8q24 locus and the risk of colorectal cancer in JapaneseKeitaro Matsuo
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
BMC Cancer 9:379. 2009..Although the association with the identified loci was strong, information on its impact in combination with lifestyle factors is limited...
ABO genotype and the risk of gastric cancer, atrophic gastritis, and Helicobacter pylori infectionMakoto Nakao
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Chikusa ku, Nagoya, Japan
Cancer Epidemiol Biomarkers Prev 20:1665-72. 2011....
Identification of MGB1 as a marker in the differential diagnosis of lung tumors in patients with a history of breast cancer by analysis of publicly available SAGE dataTakaomi Koga
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Research Institute, Nagoya, Japan
J Mol Diagn 6:90-5. 2004..This suggests that MGB1 can serve as a differential molecular marker. In practice, prospective examination, using the nine cases with a history of breast cancer, confirmed the usefulness of MGB1 in differential diagnosis...
Relationship of deregulated signaling converging onto mTOR with prognosis and classification of lung adenocarcinoma shown by two independent in silico analysesHiromichi Ebi
Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine, Nagoya, Japan
Cancer Res 69:4027-35. 2009..Our results clearly show the existence of gene set-definable, intrinsic heterogeneities in lung adenocarcinomas, which seem to be related to both clinical behavior and sensitivity to agents affecting the identified pathways...
Reduced expression of class II histone deacetylase genes is associated with poor prognosis in lung cancer patientsHirotaka Osada
Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan
Int J Cancer 112:26-32. 2004..Results of clustering analyses imply that class II HDAC genes may be regulated by a similar mechanism and deregulated during cancer development...
Immunohistochemical detection of EGFR mutation using mutation-specific antibodies in lung cancerAtsuko Kitamura
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan
Clin Cancer Res 16:3349-55. 2010..We used immunohistochemistry to examine recently developed antibodies specific to major hotspot mutations of L858R and DEL E746-A750...
Reciprocal and complementary role of MET amplification and EGFR T790M mutation in acquired resistance to kinase inhibitors in lung cancerKenichi Suda
Department of Thoracic Surgery, Aichi Cancer Center Hospital, 1 1 Kanokoden, Nagoya, Japan
Clin Cancer Res 16:5489-98. 2010..In this study, we explored their relationship using in vitro models and autopsy specimens...
Gene expression-based, individualized outcome prediction for surgically treated lung cancer patientsShuta Tomida
Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya 464-8681, Japan
Oncogene 23:5360-70. 2004..Overall, these findings should advance not only our understanding of the biology of lung cancer but also our ability to individualize postoperative therapies based on the predicted outcome...
Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implicationsTakayuki Kosaka
Departments of Thoracic Surgery and Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan
Cancer Res 64:8919-23. 2004..EGFR mutations define a distinct subset of pulmonary adenocarcinoma without KRAS mutations, which is not caused by tobacco carcinogens...
Characteristic methylation profile in CpG island methylator phenotype-negative distal colorectal cancersByonggu An
Division of Molecular Oncology, Aichi Cancer Center Research Institute, Chikusa ku, Nagoya 464 8681, Japan
Int J Cancer 127:2095-105. 2010....
Epidermal growth factor receptor mutations in small cell lung cancerAkiko Tatematsu
Department of Pathology, Aichi Cancer Center Hospital, Kanokoden, Chukusa ku, Nagoya, Japan
Clin Cancer Res 14:6092-6. 2008..According to this adenocarcinoma-specific nature of EGFR mutation, analysis of EGFR mutations with small cell lung cancers (SCLC) may provide a clue to its histogenesis...
Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survivalJunichi Takamizawa
Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan
Cancer Res 64:3753-6. 2004..This study represents the first report of reduced expression of let-7 and the potential clinical and biological effects of such a microRNA alteration...
Aquaporin 1 water channel is overexpressed in the plasma membranes of pancreatic ducts in patients with autoimmune pancreatitisShigeru B H Ko
Department of Gastroenterology, Nagoya University Graduate School of Medicine, Nagoya, Japan
J Med Invest 56:318-21. 2009..Further study would be required to elucidate the precise molecular mechanism for the role of AQP1 in pancreatic fluid secretion from the pancreas in diseases characterized by the impaired ductal fluid secretion such as cystic fibrosis...
Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for pre-treated metastatic colorectal cancer harboring wild-type KRASKohei Shitara
Department of Clinical Oncology, Aichi Cancer Center Hospital, Nagoya, Japan
Jpn J Clin Oncol 40:699-701. 2010..The primary endpoint is response rate. The secondary endpoints include adverse events, progression-free survival and overall survival. The pharmacokinetics of cetuximab will also be evaluated in five patients...
PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patientsHideki Endoh
Department of Thoracic Surgery, Aichi Cancer Center Central Hospital, Nagoya, Japan
J Thorac Oncol 1:629-34. 2006..CONCLUSIONS: An evaluation of the KRAS mutation, as well as PIK3CA and PTEN expression, might help identify lung cancer patients who are most suitable for gefitinib treatment...
Current concept of endoscopic ultrasound-guided fine needle aspiration for pancreatic cancerNobumasa Mizuno
Department of Gastroenterology, Aichi Cancer Center Hospital, Nagoya, Japan nobumasa aichi cc jp
Pancreatology 11:40-6. 2011..This review highlights the diagnostic potential of EUS-FNA, as well as its current indications and contraindications, complications, and techniques...
Lapatinib plus trastuzumab for a patient with heavily pre-treated gastric cancer that progressed after trastuzumabKohei Shitara
Department of Clinical Oncology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Aichi, Japan
Jpn J Clin Oncol 41:663-5. 2011..In this case, trastuzumab plus lapatinib resulted in durable stable disease, despite the appearance of progression during prior chemotherapy with trastuzumab...
ABO blood group alleles and the risk of pancreatic cancer in a Japanese populationMakoto Nakao
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
Cancer Sci 102:1076-80. 2011..Further studies are necessary to define the mechanisms by which the ABO gene or closely linked genetic variants influence PC risk...
Regulation of DNA polymerase POLD4 influences genomic instability in lung cancerQin Miao Huang
Division of Molecular Carcinogenesis, Nagoya University Graduate School of Medicine, Aichi Cancer Center Research Institute, Nagoya, Japan
Cancer Res 70:8407-16. 2010..Together, our findings suggest that reduced expression of POLD4 plays a role in genomic instability in lung cancer...
Clinical features and prognosis of gastric MALT lymphoma with special reference to responsiveness to H. pylori eradication and API2-MALT1 statusTsuneya Nakamura
Department of Endoscopy, Aichi Cancer Center Hospital, Nagoya, Japan
Am J Gastroenterol 103:62-70. 2008..We analyzed a consecutive series of gastric MALT lymphomas at our institution regarding treatment, clinical course, and prognosis, with special reference to responsiveness to H. pylori eradication and presence of API2-MALT1...
RASSF1A gene inactivation in non-small cell lung cancer and its clinical implicationHideki Endoh
Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
Int J Cancer 106:45-51. 2003..0247). Epigenetic silencing of RASSF1A is a frequent event in non-small lung cancer and will provide novel opportunities to develop diagnosis and therapy of NSCLC...
Epidermal growth factor receptor in relation to tumor development: EGFR gene and cancerTetsuya Mitsudomi
Department of Thoracic Surgery, Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital, Nagoya, Japan
FEBS J 277:301-8. 2010..The biological significance of such mutations and their relationship with other activated genes in lung cancers are also discussed...
The sensitivity of lung cancer cell lines to the EGFR-selective tyrosine kinase inhibitor ZD1839 ('Iressa') is not related to the expression of EGFR or HER-2 or to K-ras gene statusTakeshi Suzuki
Department of Pulmonary Medicine, Aichi Cancer Center Hospital, 1-1 Kanokoden, Chikusa-ku, Nagoya 464-8681, Japan
Lung Cancer 42:35-41. 2003..These findings warrant future study to clarify how ZD1839 inhibits lung cancer cell growth and to find a useful marker for prediction of sensitivity to this novel and promising agent for the treatment of lung cancers...
Reduced expression of Dicer associated with poor prognosis in lung cancer patientsYoko Karube
Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan
Cancer Sci 96:111-5. 2005....
[Translational research on lung cancer--EGFR gene mutation]Takayuki Kosaka
Dept. of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
Gan To Kagaku Ryoho 32:750-8. 2005..It is ultimately necessary to identify non-tobacco-related carcinogens that cause EGFR mutations for effective prevention of lung cancer...
Serum tumor antigen REG4 as a diagnostic biomarker in pancreatic ductal adenocarcinomaReiko Takayama
Department of Gastroenterology, Aichi Cancer Center Hospital, 1 1 Kanokoden, Chikusa ku, Nagoya, Aichi 464 0021, Japan
J Gastroenterol 45:52-9. 2010..Serum biomarkers for the early detection of pancreatic cancer are not currently available. We evaluated the usefulness of a novel serum marker, REG4, in the diagnosis of pancreatic cancer, as compared to carbohydrate antigen (CA) 19-9...
Breast-specific expression of MGB1/mammaglobin: an examination of 480 tumors from various organs and clinicopathological analysis of MGB1-positive breast cancersEiichi Sasaki
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Aichi, Japan
Mod Pathol 20:208-14. 2007..Secondly, as primary lung adenocarcinomas may express estrogen receptors, MGB1 expression provides further discrimination of the origin of breast cancers...
Overexpression of pituitary tumor transforming gene 1 in HCC is associated with angiogenesis and poor prognosisTsutomu Fujii
Department of Surgery II, Graduate School and Faculty of Medicine, Nagoya University, Nagoya, Japan
Hepatology 43:1267-75. 2006..PTTG1 is overexpressed in HCC and our results suggest that PTTG1 mRNA expression has prognostic significance for the survival of postoperative patients with HCC...
Neuroendocrine tumor metastasis to the thyroid glandHiroko Yamada
Department of Otorhinolaryngology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Int J Clin Oncol 12:63-7. 2007..Head and neck surgeons should be aware that a particular subset of lung cancers may develop a metastatic solitary nodule in the thyroid, as presented. An effective therapeutic strategy is largely dependent on the differential diagnosis...
Throwing new light on lung cancer pathogenesis: updates on three recent topicsShuta Tomida
Division of Molecular Oncology, Aichi Cancer Center Research Institute, Aichi, Japan
Cancer Sci 96:63-8. 2005..Second, we deal with EGFR mutations, which shows revealing specificities in various aspects. Finally, advances in the expression profiling analysis of both transcriptomes and proteomes of lung cancers are summarized...
Intraoperative diagnosis of cancer metastasis in sentinel lymph node of oral cancer patientsAkihiro Terada
Department of Head and Neck Surgery, Aichi Cancer Center Hospital, Chikusa ku, Nagoya, Aichi 464 8681, Japan
Oral Oncol 44:838-43. 2008..6%, respectively. All indexes of intraoperative frozen section analysis were superior to imprint cytology. In our experience, multislice frozen section analysis surpasses imprint cytology in intraoperative diagnosis of SLN biopsy...
Prognostic models in patients with non-small-cell lung cancer using artificial neural networks in comparison with logistic regressionTaizo Hanai
Department of Biotechnology, Graduate School of Engineering, Nagoya University, Chikusa ku, Nagoya 469 8603, Japan
Cancer Sci 94:473-7. 2003....
Phenotypic composition of salivary gland tumors: an application of principal [corrected] component analysis to tissue microarray dataHideto Iwafuchi
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center, Nagoya, Japan
Mod Pathol 17:803-10. 2004..Individual subtypes were clustered among the three dimensions of the components. This implies that salivary gland tumors may be well characterized by using only three components...
Aberrant hypermethylation of the CHFR prophase checkpoint gene in human lung cancersKotaro Mizuno
Division of Molecular Oncology, Aichi Cancer Center Research Institute, 1 1 Kanokoden, Chikusa ku, Nagoya 464 8681, Japan
Oncogene 21:2328-33. 2002..This is the first description of aberrant hypermethylation of the CHFR gene in any type of human cancer, and provides further evidence of the involvement of multiple checkpoint alterations in lung cancer...
Increased expression of COX-2 in the development of human lung cancersTakashi Takahashi
Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan
J Environ Pathol Toxicol Oncol 21:177-81. 2002..Taken together, these findings suggest that an increase in COX-2 expression maybe associated with the development of lung cancer and possibly with the acquisition of an invasive and metastatic phenotype...
Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patientsTakashi Oyama
Department of Hematology and Chemotherapy, Aichi Cancer Center, Nagoya, Japan
Am J Surg Pathol 27:16-26. 2003..Further investigations are needed to clarify the pathogenesis of this disease and to determine the optimal treatment strategy...
High-level expression of CD109 is frequently detected in lung squamous cell carcinomasTomoko Sato
Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan
Pathol Int 57:719-24. 2007..Although the detailed function of CD109 protein is unclear, these results suggest that CD109 expression may play a role in the development of lung squamous cell carcinoma...
EGFR T790M mutation: a double role in lung cancer cell survival?Kenichi Suda
Department of Thoracic Surgery, Aichi Cancer Center Hospital, Chikusa ku, Nagoya, Japan
J Thorac Oncol 4:1-4. 2009..Clarification of the pathways leading to acquired resistance is essential to maximize the efficacy of EGFR-TKI therapy for patients with lung cancer...
Detailed characterization of a homozygously deleted region corresponding to a candidate tumor suppressor locus at distal 17p13.3 in human lung cancerHiroyuki Konishi
Division of Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan
Oncogene 22:1892-905. 2003....
A 25-signal proteomic signature and outcome for patients with resected non-small-cell lung cancerKiyoshi Yanagisawa
Institute for Advanced Research, Nagoya University, Furo cho, Chikusa ku, Nagoya, Aichi 464 8601, Japan
J Natl Cancer Inst 99:858-67. 2007..Among patients with non-small-cell lung cancer (NSCLC), those with poor prognosis cannot be distinguished from those with good prognosis...
Coincidence of mammary and sentinel lymph node papillomaShu Ichihara
Department of Pathology, Nagoya Medical Center, Nagoya, Japan
Am J Surg Pathol 32:784-92. 2008..It remains undetermined whether the nodal papilloma was derived from the papilloma of the mastectomy or if it arose de novo from the breast tissue inclusion of the sentinel node...
A polycistronic microRNA cluster, miR-17-92, is overexpressed in human lung cancers and enhances cell proliferationYoji Hayashita
Division of Molecular Oncology, Aichi Cancer Center Research Institute, Japan
Cancer Res 65:9628-32. 2005....
[Molecular diagnosis of solid tumors]Yasushi Yatabe
Department of Pathology and Molecular Diagnostics, Aichi Cancer Center Hospital
Nippon Rinsho 63:434-40. 2005..In these molecular targeted therapies, diagnostic tools to verify the presence of an appropriate molecular target is crucial to the success, and thus the methods and its interpretation are discussed in this review...
EGFR mutations in patients with brain metastases from lung cancer: association with the efficacy of gefitinibShinji Shimato
Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan
Neuro Oncol 8:137-44. 2006..Gefitinib appears to be effective in treating brain metastases in a subgroup of patients. Our data suggested a possible association between the efficacy of gefitinib in the treatment of brain metastases and EGFR mutations...
Interleukin-2 potentiation of cetuximab antitumor activity for epidermal growth factor receptor-overexpressing gastric cancer xenografts through antibody-dependent cellular cytotoxicityMasayasu Hara
Division of Oncological Pathology, Aichi Cancer Center Research Institute, 1 1 Kanokoden, Nagoya, Aichi 464 8681, Japan
Cancer Sci 99:1471-8. 2008..Combination therapy with cetuximab and IL-2 would thus offer a new potential therapeutic approach for a subset of EGFR-overexpressing gastric cancers...
Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in JapaneseKeitaro Matsuo
Division of Epidemiology and Prevention, Aichi Cancer Center Research Institute, Nagoya, Japan
Cancer Sci 98:96-101. 2007..In conclusion, our case-control study clearly demonstrated that the impacts of smoking and sex on the risk of EGFRmut NSCLC are different from those for EGFRwt NSCLC. Further epidemiological evaluation is warranted...
Biological and clinical implications of EGFR mutations in lung cancerTetsuya Mitsudomi
Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, 464 8681, Japan
Int J Clin Oncol 11:190-8. 2006..These populations precisely coincide with those populations with higher response rates to TKIs. We and others subsequently confirmed and extended these findings...
Histological diagnosis of autoimmune pancreatitis using EUS-guided trucut biopsy: a comparison study with EUS-FNANobumasa Mizuno
Department of Gastroenterology, Aichi Cancer Center Hospital, and Nagoya University Graduate School of Medicine, 1 1 Kanokoden, Chikusa ku, Nagoya, 464 8681, Japan
J Gastroenterol 44:742-50. 2009..The aim of this study was to evaluate the feasibility and safety of endoscopic ultrasonography (EUS)-guided trucut biopsy (TCB) for diagnosis of autoimmune pancreatitis (AIP)...
Controversy about small peripheral lung adenocarcinomas: how should we manage them?Takayuki Fukui
Department of Thoracic Surgery, Aichi Cancer Center Hospital, Nagoya, Japan
J Thorac Oncol 2:546-52. 2007....
ASH1 gene is a specific therapeutic target for lung cancers with neuroendocrine featuresHirotaka Osada
Division of Molecular Oncology, Aichi Cancer Center Research Institute, Chikusa, Nagoya, Japan
Cancer Res 65:10680-5. 2005..The present study therefore suggests that ASH1 plays a crucial role in lung cancer development and may be an effective therapeutic target in lung cancers with neuroendocrine features...
